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Upon study of the calf afflicted with the weak calf syndrome, the 
absence of a normal thymus development was observed. It was also 
observed that weak syndrome calves could not elicit a delayed 
hypersensitivity skin reaction to purified protein derivative of 
tuberculin even after repeated injections of Mycobacterium bovis 
strain BGG. The absence of delayed hypersensitivity was hypothesised 
to be a result of a depressed or absent thymic lymphocyte (T-cell) 
population. Since neonatal thymectomized mice given thymosin were 
able to reconstitute a functional T-cell population, thymosin was 
believed to have a similar effect on weak syndrome calves. More 
specifically, the immunocompetence of the peripheral T-cell 
population in weak syndrome calves was monitored to determine 
if administration of thymosin reconstituted the T-cell 
population. The immunocompetence of the peripheral T-cell popu­
lation in weak syndrome and normal calves was determined before 
administration of thymosin. 
Uptake of tritiated thymodine by phytohemagglutinin (PHA) was used to 
monitor the immunocompetence of the peripheral T-cell population, This 
type of assay measures the stimulatory effect of the non-specific mitogen 
PHA on the T-cell population which can be used to determine the 
immuneompetence of this lymphocyte population. Whole blood was 
used for the blastogenesis cultures since the physical separation 
of peripheral lymphocytes could not be attained in calf peripheral 
blood samples. The immunocompetence of the T-cell population was 
determined prior to and after one injection of thymosin (1000 jigm). 
Both weak syndrome and normal calves of varying ages were used. To 
determine if thymosin would increase the number of lymphocytes in the 
peripheral blood, total and differential WBC counts were performed 
at the time blastogenesis cultures were done. 
It was determined that the T-cells from weak syndrome calves would take 
up a significantly lower amount of radioactive thymidine than the 
T-cells from normal calves. After administration of thymosin there was 
no significant difference in the amount of tritiated thymidine uptake 
between the T-cells from both calf groups. Any increase in the total 
lymphocytes after thymosin was not large enough to account for the 
increased stimulatory effect seen in T-cells from weak syndrome calves. 
Therefore, it was hypothesised that thymosin induced the maturation 
of peripheral T-cells in weak syndrome calves. An added effect of 
administration of thymosin which was not fully understood was the very 
rapid improvement in the general health of weak syndrome calves after 
one injection of thymosin. 
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Chapter 1 
INTRODUCTION 
Experimental work done prior to 1961 failed to establish the 
immunological function of the thymus. Thymectomies performed on a 
variety of adult animals resulted in little or no significant effect 
on antibody production. However, thymectomies performed on neonatal 
mice (4?) and rabbits (l) resulted in a marked depletion of circulating 
lymphocytes. Further experiments showed that this procedure resulted 
in decreased antibody to some antigens, and failure to reject skin 
grafts. Currently the thymus is believed to be the organ in which 
immunocompetent thymic lymphocytes are produced or are induced to 
differentiate. These thymic lymphocytes migrate to peripheral lymphoid 
tissue where they function as effector cells of cell-mediated immunity 
and helper cells in the antibody response to some antigens. With the 
isolation and purification of thymic extracts, some workers (29» 8l) 
attributed an endocrine function to the thymus. 
The thymus is the first lymphoid organ to develop (31). Within 
the thymus one of the two classes of lymphocytes that are known today 
develops into mature immunocompetent cells. These thymic lymphocytes 
migrate to the interfollicular and deep cortical areas of lymph nodes 
and the periarteriolar areas of the white pulp in the spleen. The 
thymic lymphocytes (T-cells) can be differentiated from the thymic 
independent lymphocytes (B-cells) on the basis of surface antigens, 
1 
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immune functions, and activity associated with mitogenic substances. 
A comparison between T-cells and B-cells is provided in table 1. At 
about the onset of puberty, the thymus begins to involute (?) and 
becomes smaller that it was at birth (3l). 
On the basis of structure and function, Clark (13) has divided the 
thymus into four distinct regions* (l) the outermost subcapsular 
cortex where large lymphocytes proliferate to produce new T-cells, 
(2) the inner-cortex into which newly produced T-cells migrate, (3) the 
medullar proper contained within the thymic parachyma where mature 
T-cells collect, and (4) the perivascular connective tissue space. 
The composition of the framework is anastomosing trabeculae of epithe­
lial cells accompanied by a well defined basement membrane (30). 
Histologically, the cellular contents of the thymus include epithelial 
and mesenchymal reticular cells, small, medium and large lymphocytes, 
macrophages, medullary inclusion cells and fibroblasts (?0, 71). Some 
epithelial stroma cells in the medulla develop into Hassall's 
corpuscles which are characteristic of the thymus. 
In mammals the thymus develops embryologically from the third 
and fourth pharyngeal pouches. The epithelial buds of ectoderm and 
endoderm grow out, pinch off and migrate to the midline of the upper 
thorax (50). After the epithelial structures have developed, the 
thymus is infiltrated with precursor lymphocytes or stem cells. The 
derivation of these precursor lymphocytes is still controversial. Some 
believe that these lymphocytes are of mesenchymal origin and invade the 
gland secondarily from the embryonic yolk sac or liver of the fetus and 
the adult bone marrow after the entrance of blood vessels and connective 
Table 1 Comparison of B and T lymphocytes (21) 
Properties B-cells T-cells 
Differentiation Bursa of Fabricius 
(in birds) or as 
yet unknown in 
mammals 
Thymus 
Ag-binding receptors 
on cell surface 
Abundant Igs Nature of specific 
receptors is uncer­
tain 
Cell surface 
antigens 
9 
TL 
Ly 
PC + 
H-2 transplantation * 
Approximate frequency {%) 
Blood 15 
lymph (thoracic duct) 10 
Lymph node 15 
Spleen 35 
Bone marrow Abundant 
Thymus Rare 
Functions 
Secretion of anti- yes 
body molecules 
Helper function no 
Effector cell of cell-
mediated immunity no 
Distribution in lymph 
nodes and spleen 
+ 
+ 
+ 
Clustered in follicles 
around germinal 
centers 
85 
90 
85 
65 
Few 
Abundant 
no 
yes 
yes 
In interfollicular 
areas 
Mitogenlc substances 
PHA 
Con A 
FWM 
LPS 
no 
no 
yes 
yes 
yes 
yes 
no 
no 
tissue into the thymus (50). The second viewpoint is that the precur­
sor thymic lymphocytes are derived by direct transformation of epithe­
lium cells within the thymic rudiment and are of ectoderm-endodermal 
origin (74). 
The precursor stem cells migrate into the subcapsular cortex of 
the thymus and become lymphoblasts. As these lymphoblasts move from 
the subcapsular cortex, through the inner-cortex, toward the thymus 
medulla, they decrease in size. Prom the cortical area small immuno­
competent thymic lymphocytes enter the circulation of the blood and 
thoracic lymph duct migrating to the spleen and lymph nodes. 
The maturation of T-cells involves specific changes in mitotic 
activity and cell surface antigens (52, 6l, 80). The large and medium 
lymphoblasts, which compose about 10% of the thymus lymphocyte popula­
tion, can be separated from small, nondividing lymphocytes by density 
gradient centrifugation. Using this technique, it has been shown that 
thymic lymphocyte immune functions are not developed until the small or 
medium lymphocytes are formed (86) and that the thymic lymphocyte 
found in the lymph nodes and spleen is similar to the small and medium 
lymphocyte of the thymus (15, l6). During these experiments many small 
lymphocytes were noted within the thymus. Some of these small lymphocytes 
were not immunocompetent and did not have the same surface antigens as 
the peripheral thymic lymphocytes. These cells were considered either 
to be dead-end lymphocytes or a separate subpopulation of thymic 
lymphocytes. 
On the basis of surface antigens, the lymphocytes of the thymus 
can be divided into two groups. The largest group, about 85$ in the 
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mouse strain studied, has the TL antigen, high levels of theta antigen 
and low levels of H-2. The antigenic properties of the smaller 
population are similar to those of peripheral thymic lymphocytes. These 
are the absence of TL antigen, low levels of theta and high levels of 
H-2 antigens (68), suggesting the presence of small lymphocyte subpop-
ulations with different activities. Further evidence for this is that 
the thymic lymphocytes involved in the graft-vs-host reaction and 
tumor graft rejection are morphologically different (46). 
With the more complete understanding of developmental processes 
of a competent immune system, some of the immunological deficiency 
diseases can be explained. The failure of the third and fourth 
pharyngeal pouches to undergo differentiation necessary to form the 
thymus is an example of the classic condition known as DiGeorge's 
syndrome (24, 43). The T-cell population is virtually absent while 
the B-cell line development is not impaired and functions normally, 
except where helper T-cell activities are required (18). Transplanta­
tion of fetal thymus tissue into patients with this syndrome has 
produced a correction of T-cell and cell-mediated immunity (3i 4, 14). 
In addition to the thymic aplasia seen in DiGeorge,s syndrome, some 
infants with thymic dysplasia have isolated T-cell deficiencies. The 
thymus is small and consists almost entirely of epithelial cells with 
no Hassall's corpuscles (18). 
A similar athymic condition has been described in "nude" mice (54). 
A rudimentary nonfunctional thymus which will not support thymic lympho­
cytes has been found in these mice and, therefore, these mice have 
a depressed population of thymic lymphocytes (22, 84). Although there 
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Is a population of theta-bearing lymphocytes, these mice have been 
generally used to study immunological processes in which the T-cell 
does not partake (62, 63). These mice are highly susceptible to 
infections, have a retarded or runted growth and exhibit a wasting 
syndrome if kept in a conventional environment (65). Some endocrine 
functions of the nude mice have been found to be abnormal suggesting 
an interrelationship between the thymus and other endocrine glands (7). 
An artifically induced situation similar to nude mice is seen when 
neonatal animals are thymectomized. When thymectomies are performed 
during the neonatal stage mice develop a wasting syndrome with an 
arrest of development and eventual degeneration of thymic dependent 
lymphoid tissue and depression of cell-mediated immunity (46). 
Thymectomies In adult animals result In a gradual loss of circulating 
immunocompetent lymphocytes without the rapid development of a wasting 
syndrome (48). This would suggest that the thymus is a very important 
organ in the development and maintenance of a competent immune system. 
In addition to the syndromes mentioned above, several viral infec­
tions of fetal and neonatal animals have deleterious effects upon the 
thymus and, in turn, the immune system. When reovirus type 3 is used 
to inject neonatal mice, a very severe disease develops and only 1% of 
mice survive the acute stage of the infection (85). Those mice that 
survive the acute stages show the wasting syndrome (73) and frequently 
manifest lymphomas (38, 56) • The involuted thymus noted at necropsy 
could have been a direct result of the infection or an indirect result 
of stress. A depression of cell-mediated immunity has been found 
in children Infected with measles virus as a result of a loss of 
7 
cellularity of the thymic cortex (82). An agent, possibly a herpes­
virus, that produces an acute massive necrosis of the medulla and 
cortex of the thymus has been isolated from mice (55» 6*0. 
Although the immunobiological effects of the thymus seem quite 
clear, the relation of this gland to the endocrine glands is still 
unclear (29» 8l). In studying the anterior hypophysis of thymectomized 
mice, Pierpaoli and Sorkin (8, 58) found degranulation and hypertrophy 
of the acidophilic cells of this endocrine gland. In mice the involu­
tion and atrophy of the thymus occurred when growth hormone production 
was curtailed (59). This effect has also been demonstrated in rats (17). 
Sexual maturation and onset of puberty of female mice can be delayed 
when mice are thymectomized (7). Pierpaoli and Besedosky (57) found 
that newborn athymic "nude" mice acquired the capacity to reject skin 
grafts following passive transfer of immunocompetent lymphocytes. 
However, this therapy did not result in alleviating the retarded growth, 
changes in blood levels of thyroxine or delayed onset of puberty 
ordinarily noted in "nude" female mice. These investigators (57) 
hypothesize that the effects of the thymus on the thyroid, adrenal 
and ovaries may be a result of thymus involvement in some functions 
of the brain and in the programming of certain endocrine functions 
exerted during fetal and perinatal life. 
Several different extracts of the thymus have been prepared. 
Table 2 lists some of the extracts, molecular weight, biochemical make­
up and the principle biological effect attributed to each extract. 
The protein thymic extract, thymosin, isolated by Goldstein and 
White (27, 28) has been studied more thoroughly than the other extracts. 
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Administration of this extract has resulted in reconstitution of the 
impaired immunological response in X-irradiated mice (26), neonatal 
thymectomized mice (42), and in New Zealand mice which have immunol­
ogical abnormalities (25). Thymosin reconstitutes the capacity of 
spleen cells from congenitally thymusless "nude" mice to evoke an 
in vitro graft-vs-host response (44). Thymosin reduces the wasting 
syndrome in neonatal thymectomized mice (2) and causes an acceleration 
of allograft rejection (32) as well as resistance to murine sarcoma 
virus induced tumors (88) and Dunnings leukemia in mice (39). 
Table 2 Thymic extracts 
Extract 
Molecular 
weight 
Thymosin (27) 12,000 
Thymoprotein 7000 
I & II (30) 
Lymphocyte 
stimulating 
hormone (45) 
LSHh 15,000 
LSHp 80,000 
Thymosterin (60) 
Biochemical 
nature 
protein 
polypeptide 
protein 
steroid 
Biological 
attributes 
reconstitutes 
cellular 
immunity 
T-cell differ­
entiation 
WBC differen­
tiation & 
antibody 
production 
Antiprolifera­
tive activity 
& increases 
antibody 
production 
Recently thymosin has been used in a child with a deficient cell-
mediated immune system (78). The patient had thymic hypoplasia and 
abnormal immunoglobulin synthesis with a depressed percentage of T-cell 
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rosettes. Although the patient had sepsis caused by Candida albicans 
during infancy, ahe was unable to elicit delayed hypersensitivity 
skin tests to mumps virus, C. albicans or purified protein derivative 
to tuberculin. Thymosin therapy was instituted after it was shown 
that In vitro incubation of her lymphocytes with thymosin increased the 
percentage of T-cell rosettes. During the course of treatment, which 
involved 23 intramuscular injections of 1 mg per kilogram per day of 
thymosin, the percentage of T-cell rosettes gradually increased to 
normal, and positive delayed hypersensitivity skin test developed. A 
recent report of the patient's course showed that there was an Increased 
number of total lymphocytes and percentage of spontaneous T-cell 
rosette formation. Positive delayed hypersensitivity responses have 
been maintained for one and one-half years, and there was an increased 
immunoglobulin G and M levels. However, the patient's in vitro 
lymphocyte response to phytohemagglutinin (PHA) and mixed lymphocyte 
culture remained markedly depressed (77). 
The in vitro effects of thymosin studied so fax have been the 
ability of the preparation to stimulate the unmasking of T-cell 
markers on precursor cells (kO, kl) and to confer on precursor cells 
the sensitivity to azothioprine, anti-lymphocyte serum and antl-theta 
serum (5). The mechanism of action for unmasking of T-cell markers 
by thymosin has not been completely elucidated, but it is believed to 
be mediated by cyclic nucleotides (67). It can be seen that the 
immunological properties attributed to the thymus can be reconstituted 
by the administration of the thymic extract thymosin. As of this date 
the endocrinological effects of thymosin have not been studied. 
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The basic concept of the Immune response can be applied to 
cattle even though most work has been done on other mammalian models. 
The first circulating lymphocytes appear at the 60th day of gestation 
in cattle (?2). Although the calf is hypogammaglobulinemia in utero 
due to the lack of transplacental transfer of maternal immunoglobulins. 
The bovine fetus is capable of producing antibodies as early as the 
l64th day of gestation (83). Most calves surviving intrauterine 
infection with bovine viral diarrhea virus (BVD) have been found to be 
producing the specific Immunoglobulin prior to birth (10,12). The rise 
in concentration of 11 ̂ -hydroxycorticosteroid from th 20th day prior 
to parturition in the fetal blood probably accounts for the depressed 
T-cell response to mitotic stimulation (51). With this depression of 
the neonatal calf's immune system, it is believed that the high 
concentration of maternal immunoglobulins in colostrom enhances the 
ability of these calves to resist infection (51). As the calf becomes 
older the peripheral thymic lymphocytes become responsive to mitotic 
stimulation with PHA (^9). 
During the study of the "weak calf" syndrome of western Montana, 
it became apparent that the cell-mediated immunity of a large number of 
afflicted calves was depressed. Many of those surviving the initial 
delayed hypersensitivity reaction to protein derivative of tuberculin 
or extracts of BGG (?5»79). Serum immunoglobulin M and immunoglobulin G 
concentrations of precolostral calves afflicted with the weak calf 
syndrome and normal calves are not significantly different (3^). 
Although the etiological agent has not been identified, a viral agent 
which will transform tissue cultures has been repeatedly isolated from 
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infected kidney and salivary glands of afflicted calves (35.36). 
Recently an experimental infection with a clinical isolate of bovine 
adenovirus type 5 Induced lesions closely resembling those seen in 
naturally occurring weak calf syndrome (19,20). Upon necropsy of 
aborted calves or those succumbing to the infection soon after birth, 
the thymus gland was noted to be severely involuted or absent (53). 
The glands, when present, weighed only one-tenth that of normal animals 
of comparable age (79). Severe leukopenia with an average WBC of 
1 x 103 WBC/mm3 was characteristically measured in comparison to 
2.2 x lO4 WBC/mm3 counted in normal calves. The depression was only 
transitory since a leukocytosis was generally detected from about the 
4th day. A normal observation in these calves was their inability 
or unwillingness to nurse. Therefore, death was frequently directly 
attributed to dehydration. In past years only whole immune serum has 
been helpful as supportive therapy. The calves appeaxed not to 
respond directly to antibiotic therapy although the reduction of 
secondary bacterial infections was probably a beneficial consequence. 
Several calves given the whole immune serum lived for more than a year, 
but these calves were runted and failed to gain any appreciable weight 
or attain the size of normal animals in spite of being provided adequate 
and ample feed. These calves could not elicit a delayed hypersensitivity 
reaction even when injected with two doses of the Paris strain of BGG 
grown in the laboratory and later challenged with BCG extracts. It 
was surmised from the above data that although the calves were able 
to survive with the therapeutic treatment used, their thymus gland 
was severely affected by the initial in utero infection causing a 
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depression in the cell-mediated immunity and possibly resulting in the 
runting observed. 
Statement of the problem 
With the involvement of the thymus, these calves manifest a syndrome 
that resembles very closely the "wasting" syndrome seen in mice 
thymectomized neonately. Since this "wasting" syndrome in mice has 
been reversed by the administration of the thymic extract thymosin (42), 
this study was undertaken to determine whether the administration of 
thymosin to the "weak syndrome" calves could elicit similar responses. 
The study, however, was limited to the in vitro effects of the thymic 
extract of the T-cell population. 
Chapter 2 
MATERIALS AND METHODS 
Processing of thymic extract 
Thymosin was extracted from bovine thymus glands by a modifica­
tion of Goldstein and White's method (2?). Frozen bovine thymus glands 
were obtained from a local abattoir. The glands were cut into small 
pieces and processed as follows: 
1. Homogenize thymus glands in Waring blender with 0.85$ NaCl. 
2. Centrifuge the blended mixture in 250 ml plastic centrifuge 
bottles at 3.500 x G in a Universal centrifuge for 5 minutes at h° C. 
3. Remove the fluid and place 300 ml in a 500 ml glass flask. The 
flask is then placed in an 80° C water bath for 15 minutes. 
k. Gentrifuge the fluid at 3»500 x G in a Universal centrifuge for 
5 minutes and remove the clear fluid. 
5. Centrifuge the clear fluid at 16,000 rpm for one hour and retain 
the supernatant and discard the precipitate. 
6. Precipitate with acetone at -k° C. The clear supernatant is 
added to 10 volumes of cold acetone with constant stirring. A 
precipitate forms and coaleses following stirring for 5 minutes. 
7. Place the precipitate in an evaporating dish overnight in the 
cold room. 
8. Resuspend the dried precipitate in 0.1 M phosphate buffer (pH 7.2) 
by constant stirring for three hours. Centrifuge at 3»500 x G and 
13 
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save supernatant. 
9. A second precipitation is accomplished with saturated ammonium 
sulfate, (NH^gSO^. Add the (NH/^SO^ to the supernatant until a 
final concentration of $0^5 is attained. This precipitation is done 
at ambient temperatures. Centrifuge the mixture and save the preci­
pitate . 
10. Suspend the precipitate in distilled water and dialize over­
night against two changes of distilled water. 
11. Lyophilize the suspension. A fluffy white to whitish-brown 
powder is obtained with completion of the procedure. 
Although chemical and physical analyses were not performed using 
this material extracted from the thymus glands, the extract will be 
referred to as "thymosin" throughout the text. 
Administration of extracts 
For injection into calves the lyophilized thymosin was suspended 
in sterile 0.1 M phosphate buffer or peanut oil. The extract was 
sterilized by placing under an ultraviolet lamp for at least three 
hours. The appropriate weights of thymic extract were suspended in 
the diluent to give a final concentration of 100 jugm/ml or 25,000 
^igm/ml. Bovine serum albumin (BSA) was suspended in 0.1 M phosphate 
buffer to be used as a control- Dr. J. K. Ward, a Hamilton veterin­
arian administered the materials to all calves. 
Collection of blood samples 
Venous blood samples were collected by Dr. Ward from calves. 
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Blood was collected prior to any Injection to establish baseline 
values and at selected intervals after the administration of test 
materials the calves were bled again. Preservative-free heparin In 
concentration of 50 units/ml of blood was added at the time the blood 
was drawn. The blood was kept at ambient temperature during trans­
portation, or for approximately four hours. White blood cell (WBC) 
counts were done with a Coulter Counter (Model ZBI). At this time two 
blood smears were made for differential WBG counts and serum was 
collected for later analysis. 
Blastogenesls cultures 
Problems, which are explained later, in separation of peripheral 
calf lymphocytes from erythrocytes required the use of whole peripheral 
blood cultures (PBC) for blastogenesis studies (6,^9). 
The peripheral blood cultures were prepared in tissue culture 
medium composed of RPMI 1640 (Difco), table 3» with 10% fetal calf 
serum (Microbiological Associates) and 2% Hepes buffer (Difco). 
A flow chart outlining the procedure is provided in figure 1. 
Briefly, a volume of whole blood was suspended in 30 ml of tissue 
culture medium to give a final concentration of 1 x 10^ WBC/ml. 
The medium suspension was mixed thoroughly to insure an equal distri­
bution of cells. Triplicate control samples of 1.0 ml each were 
removed and placed into glass tissue culture tubes prior to the 
addition of phytbhemagglutinin-P (PHA-P). Next, the concentration of 
PHA-P to be used was added to the stock suspension of blood culture; 
triplicate samples of 1.0 ml each were placed in glass tissue culture 
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Table 3 Preparation of medium and stock solutions 
RFMI 1640 
Triple distilled water 1.0 liter 
RPMI 1640 dry powder (Difco) 6.5 g» 
Penicillin G 1000 units 
Streptomycin sulfate 1000 ̂igm 
NaHCO^ .. 1.5 gm 
Fetal calf serum, inactivated at 56° C for 
30 minutes (Microbiological Associates).... 100 ml 
Hepes buffer, 1.0 molar (Gibco) 20 ml 
The medium was filter sterilized prior to the addition of serum 
and Hepes buffer. When all materials had been added together, 
the medium was stored at 4° C until used. 
Tritiated thymidine stock solution 
Thymidine, Methyl-^H, ImCi, Specific activity 
71.5 Ci/mmole (ICN) 1 ml 
RPMI 1640 with 10# fetal calf serum 99 ml 
Solution at concentration of 10 jxCl/ml was stored at 4° C in a 
serum bottle. 
Stock PHA-P solution 
PHA-P (Difco) 1 ml 
RPKI 1640 with 10% fetal calf serum 9 ml 
Solution stored in a calibrated dropper bottle (0.05 ml/drop) 
at -70° G. 
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Figure 1 Flow chart of procedures for preparation of blastogenesis 
cultures from peripheral blood samples 
Suspend enough peripheral blood in 30 ml of RPMI 1640 to give a final 
concentration of 1 x 10" cells/ml. 
Withdraw triplicate 1-ml samples 
for no PHA-P control cultures. 
To 20 ml of original solution add 0.1 ml of stock PHA-P (100 jil/ml), 
table 3, solution - final concentration of PHA-P is 0.5jil/ml. 
• Withdraw triplicate 1-ml samples 
for 0.5>il/ml PHA-P cultures. 
To 10 ml of the above solution add 0.05 ml of stock PHA-P solution -
final concentration of PHA-P is 1.0 ̂l/ml. 
^ Withdraw triplicate 1-ml samples 
for 1.0 ̂il/ml PHA-P cultures. 
To 5 ml of the above solution add 0.45 ml of stock PHA-P solution -
final concentration of PHA-P is 10 pl/ml. 
Withdraw triplicate^.-ml samples for 10 jil/val PHA-P cultures. 
Incubate at 36° C and 5% CO2 for 72 hours before addition of Q.l ml 
of stock tritlated thymidine (10 jiCi/ml) to each culture - final 
concentration of tritiated thymidine is 1 uCi per culture. 
I 
Incubate at 36° and 5% CO2 for an additional 24 hours before termina­
tion of incubation period by placing the cultures in a cold room at 4° G. 
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tubes. The concentrations of 0.5 ;ul/ml, 1.0 >»l/ml and 10 jud/ml of 
PHA-P Here used in the initial experiments, but when the 10 yul/ml 
of PHA-P was found to inhibitory to the mitotic activity, this 
concentration was abandoned. The cultures were incubated at 36° C 
and in 5% CO2 in a gas chamber. After incubation for 72 hours, the 
tritiated thymidine (ICN) was added. A 0.1 ml volume of the stock 
tritiated thymidine (specific activity 71.5 Ci/mmole) was added to 
each culture tube. The mitotic activity was terminated 24 hours 
after the addition of tritiated thymidine by placing the cultures 
in a cold room at 4° C. The cultures were then processed for counting 
by liquid scintillation. 
Processing of radioactive samples 
When the blastogenesls samples were ready for counting, each suspen­
sion was processed following the procedure outlines in figure 2. The 
technique used involved collecting the incorporated radioactive 
thymidine on a filter paper. The cells were collected on Whatman GF/C 
filter paper. Red blood cells were lysed and all debris washed through 
with cold Jfo acetic acid. The cellular nucleic acids were precipitated 
with 10/S trichloracetic acid and the filter papers were dried in an 
oven at 65° C prior to the addition of the scintillation fluor. The 
waste fluid collected in the vacuum container was disposed in a 
receptacle for radioactive liquid waste. After the filter papers 
had dried, a volume of 10 ml of scintillation fluor was added to 
each vial containing a single filter paper. The sample vials were 
counted for ten minutes in a Nuclear Chicago Unilux III liquid 
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Figure 2 Flow chart Indicating processing procedures for trltlated 
thymidine labeled lymphocyte* from PHA stimulated 
blastogenesis cultures 
Pour contents of test tube into filtering well which contains a damp 
Whatman GF/C filter. 
t 
Rinse tube with k ml of cold (4° C) 3% acetic acid and pour contents 
of tube into filtering well. 
J 
Turn on vacuum and suction contents of well through the filter. 
I 
Release vacuum and add 1 ml of cold (4° C) 10% trichloroacetic acid 
to the filtering well. Allow to stand for 30-40 seconds. Suction 
contents of well through filter. 
I 
Wash the filter with 3 ml of cold phosphate buffered saline (pH 7.2). 
T 
Transfer filter to scintillation vial. 
1 
Dry the filter within the vial at 65° C for 1-2 hours in an oven. 
Add 10 ml of scintillation fluor (PFOjPOPOP with a toluene reagent base) 
to each vial and count the vials for 10 minutes in a liquid 
scintillation counter. 
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scintillation counter. The scintillation fluor was composed of ̂  gm 
PPO and 0.05 gm POPOP dissolved in 1 liter of reagent grade toluene. 
The scintillation fluor was usually allowed to stand overnight to 
insure that the reagents were dissolved and then the fluor was stored 
in a dark brown bottle until used. 
The results from the blastogenesis cultures were reported in 
counts per minute and are the average of triplicate cultures counted 
twice. The stimulatory index (S.I.) and culture counts (C.G.) were 
determined for each test sample. The S.I. was calculated by dividing 
the counts per minute for PHA-P stimulated cultures by the counts per 
minute for nonstimulated control cultures. The C.C. were determined by 
subtracting the nonstimulated culture counts per minute from the PHA-P 
stimulated culture counts per minute. 
Because the sample sizes were small and results were compared 
between two groups of animals, statistical analysis of the data was 
performed using the Mann-Whitney U test (69). Two groups of animals 
were considered to be significantly different if the probability 
(p value) was equal to or less than 0.05. 
Differential white blood cell counts 
The slides prepared for differential WBC counts were stained by the 
polychrome staining procedure as outlined in table 4. A total of 
100 cells was counted and the cell types analyzed under oil immersion 
to enable more accurate identification. The cell types identified were 
segmented and juvenile neutrophilic granulocytes, eosinophilic granulo­
cytes, basophilic granulocytes, lymphocytes and monocytes (66). 
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Table k Staining procedure of blood smears prepared for differential 
white blood cell counts 
1. Dip blood-smear slide into absolute methanol for one second. 
2. Dip slide into eosin stain for twenty seconds. 
3. Wash slide in distilled water. 
4. Dip slide into polychrome stain for twenty seconds. 
5. Wash in distilled water and air dry. 
6. Observe under oil immersion objective lens. 
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The absolute number of lymphocytes per mm^ of peripheral blood (AL/mra^) 
was calculated when possible. This calculation was accomplished by 
multiplying the WBC count by the percentage of lymphocytes for that 
calf. 
Washing of radioactive glassware 
All glassware that came in contact with radioactive substances was 
decontaminated by soaking in 2% solution of Isoclean (isolab) overnight. 
The glassware was then rinsed three times in tap water prior to running 
through standard laboratory washing procedures for tissue culture 
glassware as followst 
1. Place in dilute acid (HCl) bath overnight. 
2. Rinse three times in tap water. 
3. Rinse three times in distilled water. 
k. Dry and sterilize in autoclave. 
Chapter 3 
RESULTS 
Lymphocyte separation 
Purified T-lymphocytes are desirable for measuring their capacity 
to respond to mitotic stimuli. Three methods of obtaining purified 
lymphocytes were compared. The separation of human and bovine 
peripheral blood was analyzed by the following: (a) ficoll-diatri-
zoate (9), (b) gelatin (87), and liquid silicone oil (37). 
(a) Ficoll-diatrizoate (FD) - FD was prepared by dissolving 
9.84 gm of sodium diatrizoate in 30 ml of distilled water 
(pH 7.3)• To this solution an additional 72 ml of distilled 
water was added followed by 6.28 gm of Ficoll. The FD 
(specific gravity 1.080) was then heat sterilized at 121° C 
and 15 psi for 15 minutes. The sterile solution was stored in 
a foil-covered container at 4° G. Prior to the separation 
procedures, FD was warmed to ambient room temperature of 24° C. 
Heparinized peripheral blood was diluted 1:2 with 0.85% saline, 
and 10 ml was carefully layered over 5 ml of FD. The sample was 
centrifuged with a swing head for 20 minutes with a force of 
400 x G at ambient temperature. Lymphocytes of human blood 
aggregated at the interface and were removed with a Pasteur 
pipette. These cells were then washed three times with tissue 
culture medium prior to suspension. However, in following the 
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same protocol, the lymphocytes from bovine calf blood could not 
be separated from the erythrocytes. After centrifuging bovine 
calf blood, the lymphocytes remained dispersed throughout the FD 
with the erythrocytes. Muscoplat et al. (49) reported that they 
were able to separate adult bovine lymphocytes with FD at a specific 
gravity of 1.080, Even by varying the specific gravity of FD 
above and below 1.080 as well as the force applied to the interface, 
the separation of calf lymphocytes still could not be attained. 
The reasons for the discrepancies were not established. 
(b) Gelatin - Ten ml of heparinized peripheral blood was 
mixed with an equal volume of 3% gelatin dissolved in TC 199 
medium. After standing at 37° C for one hour, human erythro­
cytes collected at the bottom of the test tube and leukocytes 
remained in suspension. However, the same results could not be 
obtained with bovine blood, which failed to separate even after 
reducing the gelatin concentration to 2%, The erythrocytes 
and leukocytes continued to remain in suspension. 
(c) Liquid silicone - Heparinized bovine peripheral blood was 
centrifuged at 2,500 rpm, and the buffy coat was removed along 
with 2 to 3 ml of serum. A 0.5 ml volume of liquid silicone, 
specific gravity of 1.075» (Diffusion pump oil grade) was first 
placed in the bottom of a 1-ml plastic centrifuge tube. A 
portion (l ml) of the leukocyte-rich buffy coat was then layered 
carefully on top of the oil. After centrifugation at 2,500 
rmp for 15 minutes, the leukocytes were dispersed in the diffusion 
oil, and the erythrocytes were pelleted in the bottom of the 
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centrifuge tube. The leukocytes were removed with a Pasteur 
pipette, washed free of silicone with medium and suspended in 
RPMI 1640. This method accomplished the separation of peripheral 
bovine leukocytes from erythrocytes, but the cost of liquid silicone 
was prohibitive for the large number of samples anticipated. 
Comparison of blastogenesls between whole and separated peripheral blood 
In view of the problems involved in preparing preparations of 
bovine lymphocytes, an alternative culture technique to measure blasto-
genic activity of bovine lymphocytes in the presence of PHA was 
desired. Therefore, the use of nonseparated peripheral blood was 
attempted (6, 49). A comparison of the blastogenic response to PHA 
of lymphocytes in cultures of whole human blood and of FD separated 
peripheral lymphocytes was made. 
Figure 3 shows the culture counts (C.C.), in log scale, for 
nonseparated blood and FD separated cultures stimulated with PHA. The 
C.C. for separated lymphocytes was approximately four times higher than 
that of the whole blood. Because the concentration of leukocytes in 
each group was maintained at 1 x 10^ WBC/ml, the higher C.C. with 
separated blastogenesis cultures were not surprising since these 
cultures contained a higher population of lymphocytes. The leukocyte 
population of FD-treated blood is almost 95% lymphocytes (49) whereas, 
the percentage of lymphocytes in normal peripheral human blood is 
approximately one half the total leukocytes. This would suggest that 
the C.C. shown using nonseparated whole blood in the blastogenic assays 
was comparable to the C.C. obtained by using FD separated lymphocytes. 
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Figure 3 Bar graph ropresenting a 
comparison between the culture 
counts from blastogenesls cultures 
of stimulated lymphocytes in ficoll-
diatrizoated separated and whole 
blood cultures. 
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With the problems encountered in separation of peripheral bovine 
calf lymphocytes, the above results demonstrated that with human 
blood equivalent data could be attained using nonseparated peripheral 
blood. Therefore, whole blood blastogenesis cultures could be used as 
an indication for stimulation of T-lymphocytes by PHA. 
Selection of filter paper and scintillation fluor 
The separation of residual radioactive thymidine in the culture 
medium was essential to measure the amount of the isotope that had been 
taken up by the cells during blastogenesis activity. One of the most 
common methods of attaining the separation is by filtration (?6), 
through Millipore ji membrane filter or Whatman GF/C filter paper. 
The retention of radioactive materials by the two filter types was 
compared by separating the blastogenesis cultures into two equal por­
tions and filtering the appropriate samples through each of the filters. 
Although both filter types were found to retain similar amounts of 
radioactive materials, the Whatman GF/C filter paper was selected 
because of availability and considerably lower cost. 
The scintillation fluor was the PPOtPOPOP combination dissolved 
in toluene indicated earlier, which had been suggested by New England 
Nuclear. Since the filter papers were dried prior to the addition of 
the scintillation fluor, the addition of absolute methanol was avoided. 
Determination of incubation period for blastogenesis cultures 
To determine the optimal incubation time for the maximum thymi­
dine uptake by stimulated bovine blood cultures, an incubation-time 
experiment was performed. Triplicate cultures of control and PHA-P 
blastogenesis cultures from three "normal" calves were incubated 
for periods of time varying from 24 hours to 144 hours. The 
tritiated thymidine was introduced into each culture 24 hours prior 
to the termination of the incubation period. At the end of each 
incubation time period, the cultures were precipitated with trichloro­
acetic acid and collected on filter papers, which were stored until 
the entire group was ready for counting. The scintillation fluor was 
added to each vial immediately before the samples were all counted. 
The raw data presented in table 5 shows that the highest S.I. and 
G.C. were achieved when cultures were incubated for a total of 96 hours. 
Therefore, since the maximum uptake of tritiated thymidine occurred 
after 96 hours of incubation, this time interval was used throughout 
the study. 
Studies involving newborn calves 
The selection of calves was made by Dr. J. K. Ward. Hie criteria 
used for the diagnosis of weak syndrome (WS) calves were as follows: 
rough hair, slow to stand with stiff arthritic knee joints, failure to 
nurse and a red muzzle. 
None of the calves were moved to other locations to simplify the 
study but were retained on their respective ranches to minimize any 
stress that could aggravate the existing conditions. When the syndrome 
was diagnosed, a blood sample was taken and sent from Hamilton to 
Missoula. Unfortunately, under this system the samples were frequently 
received six hours later. It should be noted that the health of some 
29 
Table 5 Tabulated data for Incubation period determination from 
normal calf PHA stimulated blastogenesis cultures 
Calf Age (wks) 
Total 
incubation 
time 
No PHA 
culture 
counts 
PHA 
culture 
counts S.I.(a) G.C.(b) 
1 4 24 448(c) 1289(c) 2.9 841 
48 694 12,776 18.4 12,082 
72 415 17,682 42.6 17,267 
96 409 19,982 48.9 19,573 
120 458 339 0.7 -119 
2 2 48 4006 17,463 4.4 13,457 
72 383 16,245 42.4 15,862 
96 253 25,610 101.2 25,357 
120 224 20,109 89.9 19,885 
144 302 29,971 99.2 29,669 
3 6 48 573 6146 10.7 5573 
72 477 13,861 29.0 13,384 
96 No data available 
120 316 8560 27.1 8244 
144 193 3374 17.5 3181 
(a) S.I. « stimulated culture counts/control culture counts 
(b) G.G. = stimulated culture counts - control culture counts 
(c) Each value expressed in counts per minute is the average of 
triplicate cultures counted twice. 
severely afflicted calves continued to deteriorate, often succumbing 
within 48 hours even after the administration of thymosin. The data 
obtained from blastogenesis studies of these calves were not included 
in the analysis. Since the incidence of WS calves is believed to be 
very high in the Bitterroot Valley and the onset of the syndrome is 
sometimes insidious, the normal calves were selected from another area. 
There were instances in which "normal" appearing calves developed 
the syndrome even up to three week after birth, but this did not 
occur with any of the normal calves used in this study. The normal 
calf blood was obtained from animals located two miles from Missoula. 
Dr. E. M. Pruyn, a Missoula veterinarian, selected and drew the blood 
samples from the normal calves. Table 6 list the calves used in this 
portion of the test of the therapeutic value. Thymosin in 0.1 M 
phosphate buffer was administered to WS calves after the initial blood 
sample was drawn. 
A table comparing the total WBC count of calves in this age group 
is given in table 7. The average number of WBC for normal newborn 
calves was 8763 and for WS calves of a comperable age, 6530. The 
WBC counts of normal calves used in this study are within the range for 
calves less than one year old as established by Schalm (66), who reported 
the average WBC count for Hereford calves to be 11,1^0 with a range of 
5750 to 17,800. The average WBC count found in WS calves was in the low 
range. 
In view of the low respone of T-lymphocytes to stimulation observed 
in perinatal calves by Osburn and co-workers (51), the T-cell blastogen­
esis response of newborn "normal" calves was investigated. Although 
31 
Table 6 Pertinent information for newborn calves used in study 
Identification 
Owner number Age Comments 
Carter 918 1 day WS calf 
Carter 81? 4 days WS calf 
Carter W10 1 day WS calf 
Carter 904 1 day WS calf 
Ward SD47 1 day WS calf 
Ward W3 1 day WS calf 
Ward 1054 1 day WS calf 
Ward K1324 3 days WS calf 
Pruyn 1 1 hour Normal calf 
Pruyn 2 10 hours Normal calf 
Pruyn 3 12 hours Normal calf 
Pruyn 4 1 day Normal calf 
Pruyn 5 1 day Normal calf 
Pruyn 6 4 days Normal calf 
Pruyn 7 7 days Normal calf 
Pruyn 8 8 days Normal calf 
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Table 7 White blood cell counts of calves 
Calf type 
Number of 
animals Age Ave. counts/mm3 Range 
Normal, newborn 8 0-10 days 8763 12,600 - 5800 
Normal 5 1-2 months 89*4-6 10,930 - 6600 
Normal 6 8-9 months 8767 11,400 - 7400 
WS, newborn 8 0-10 days 7239 14,400 - 2200 
WS 9 1-2 months 7010 11,740 - 4500 
WS 8 8-9 months 7775 9200 - 6700 
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the number of test animals was limited (a total of eight calves), the 
T-cell response to PHA-P was low during the first hours postpartum. 
The counts for control and stimulated cultures as well as S.I. and G.G. 
for each calf is given in table 8. When the S.I. is plotted in rela­
tionship to age (figure 4), the T-cell population is depressed in 
relation to stimulation with PHA-P during the first hours postpartum. 
The ability to stimulate T-cells with PHA-P increased after 48 hours 
to a level that was maintained up to 8 days. 
The results of blastogenesis studies on newborn calves afflicted 
with the weak calf syndrome is tabulated in table 9. The average S.I. 
for newborn WS calves prior to injection of thymosin was 1.5 compared 
to an average S.I. of 12.9 for newborn normal calves. Following one 
injection of thymosin (1000 jugra) in phosphate buffer, the average S.I. 
of WS calves increased to 57-8. However, this Increase is misleading 
since the blood blastogenesis cultures for the WS calves given thymosin 
were not prepared until two months after the first S.I. were determined. 
A bar graph of the S.I. for each test group is presented in figure 5. 
The G.G. for each test group are shown in the bar graph in figure 6. 
The average C.C. for normal newborn calves was 404 cpm with a range 
of -3 cpm to 853 cpm. The C.C. for WS calves prior to the administration 
of thymosin ranged from -225 cpm to 522 cpm with an average G.G. of 
101 cpm. After the administration of thymosin the G.G. for the same 
WS calves rose to an average C.C. of 1233 cpm with a range of ?29 cpm 
to 1722 cpm. 
When comparing the newborn normal calf and WS calf, the S.I. 
(p<,05) and C.C. (p<.05) are significantly different. Since the data 
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Table 8 Tabulated data for PHA stimulated blastogenesis cultures 
for normal newborn calves 
No PHA PHA 
culture culture 
Calf Age counts counts S.I.(a) G.C 
1 1 hour 11(c) 8(c) 0.7 -3 
2 10 hours 20 191 9.5 171 
3 12 hours 44 478 10.9 434 
4 24 hours 150 1003 6.7 853 
5 24 hours 14 388 27.7 374 
6 4 days 24 442 18.4 418 
7 7 days 38 600 15.8 562 
8 8 days 34 453 13.3 419 
(a) S.I. =* stimulated culture counts/control culture counts 
(b) G.C. = stimulated culture counts - control culture counts 
(c) Each value expressed in counts per minute is the average of 
triplicate cultures counted twice. 
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Figure 4 Scatter graph showing 
the stimulatory index for PHA 
stimulated blastogenesls cultures 
of newborn normal calves 
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Table 9 Tabulated data for PHA stimulated blastogenesis cultures for 
WS calves prior to and after administration of thymosin 
Calf Age 
No PHA 
culture 
counts 
PHA 
culture 
counts S.I.(a) C.G.(b) 
Prior to administration of thymosin 
Garter 918 1 day 465(c) 705(c) 1.5 240 
817 4 days 1401 1176 0.8 -225 
¥10 1 day 522 331 0.6 -191 
S 1 1 day 1957 2479 1.3 522 
Hard SD47 1 day 492 730 1.5 238 
" W3 1 day 94 169 1.8 75 
" K1328 1 day 5 149 2.6 144 
" 1054 1 day 282 288 1.0 6 
After administration of thymosin (d) 
Garter 918 2 months 27 1749 64.8 1722 
817 2 " 12 1370 114.2 1358 
" tflO 2 " 20 1610 80.5 1590 
N (JQlf, 2 " 20 1370 68.5 1350 
Ward SD47 2 • 34 763 22.4 729 
" W3 Not available 
" K1328 Not available 
" 1054 2 months 69 1035 15.1 966 
(a) S.I. =•= stimulated culture counts/control culture counts 
(b) C.C. » stimulated culture counts - control culture counts 
(c) Each value expressed in counts per minute is the average of 
triplicate cultures counted twice. 
(d) The blastogenesis cultures for this portion of the study were not 
performed until two months after the first cultures were done. 
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Figure 5 Bar graph representing 
the stimulatory index from blast-
ogeneais cultures from PHA stimulated 
cultures of newborn normal and WS 
calves. Bar lines represent range. 
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Figure 6 Bar graph representing 
the culture counts from blastogen-
esls cultures of PHA stimulated 
cultures of newborn normal and 
WS calves. Bar lines represent 
range. 
Normal calves WS calves 
prior to thymosin 
administration 
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gathered, on treated WS calves was misleading, statistical comparison 
of the treatment was not computed between prior and after administration 
of thymosin. 
Studies involving calves 1-2 months old 
In order to determine the effects of the thymic extract on chronic 
WS calves, two test groups were selected from the same herd within 
the Bitterroot Valley. The first group consisted of calves 1-2 
months old and the second group selected from the same calf crop 
were 8-9 months old. Mr. Van Meter, who ranches approximately twelve 
miles south of Hamilton, allowed his herd to be used after the initial 
arrangements were made by Dr. Ward. The test calves were kept in an 
open pasture with the other cattle belonging to the rancher. All 
animals were caught by Mr. Van Meter at the times the blood samples 
were obtained. 
Mr. Van Meter experienced a calf loss rate of approximately 2$% 
in his herd during the spring of 1975. Dr. Ward stated that this is 
about the average loss rate for herds affected with the weak calf 
syndrome for the first time in contrast to about 5 to 7% in herds 
having experienced this condition previously. The selection of calves 
to be included in the "normal" and "WS" calf groups was made by Dr. 
Ward using the same criteria stated previously. A summary of the 
calves used in this portion of the test is given in table 10. 
The blood samples were drawn by Dr. Ward from the test calves. 
With the blood collected on the initial visit, WBG count, differential 
WBG count and bl&stogenesis studies were performed. The results of these 
Table 10 Pertinent information for calves 1-2 months old 
Identification 
Owner Number Age(days) Comments 
Van Meter I8b 42 Normal, given thymo­
sin in phosphate buffer 
Van Meter Y26 42 Normal, given thymo­
sin in phosphate buffer 
Van Meter Y89 46 Normal, given thymo­
sin in phosphate buffer 
Van Meter wyt- 39 Noxmal, given BSA 
Van Meter Y96 45 Normal, given BSA 
Van Meter *75 39 WS, given thymosin 
in phosphate buffer 
Van Meter W89 29 WS, given thymosin 
in phosphate buffer 
Van Meter Y1 62 WS, given thymosin 
in phosphate buffer 
Van Meter Y121 21 WS, given thymosin 
in phosphate buffer, 
expired 
Van Meter Y66 22 WS, given thymosin 
in phosphate buffer 
Van Meter Y103 35 WS, given thymosin 
in peanut oil 
Van Meter W?8 33 WS, given thymosin 
in peanut oil 
Van Meter W32 39 WS, given BSA 
Van Meter Y63 32 WS, given BSA 
teats will be given later. During this initial visit one injection of 
(1000jugm/calf) in 0.1 M phosphate buffer, thymosin (1000 jugm/calf) 
in peanut oil or BSA (1000^lgm/calf) in 0.1 M phosphate buffer was 
administered. The proper dose of each was given by intramuscular 
injection into alternate normal and WS calves. Neither Dr. Ward or 
Mr. Van Meter was aware of which injection was given to a particular 
calf. The subsequent visit to the ranch was made one week later. 
At that time a sample of blood was drawn from each test calf for 
comparison studies. During the week one calf, Y121, that had been 
given thymosin in phosphate buffer expired. Therefore, the results 
of this calf were not included. 
The average WBC counts for each group are given in table 7. The 
average WBG count for normal calves was 8946 compared to 7134 for the 
WS animals. After the administration of thymosin in phosphate buffer, 
the average WBC count for WS calves was 7887 and 9717 for normal calves. 
The average WBC count was 6800 for WS calves given thymosin in peanut 
oil. The values obtained during the initial visit are below the average 
WBC counts of 11,400 for Hereford calves less than one year old (66) 
but are within the range of 5750 to 17»800. The differential counts, 
table 11, for normal and WS calves showed little variation between 
the groups in relation to percentages of lymphocytes and polymorphic 
neutrophils. The average percentage of lymphocytes was 77 for normal 
calves and 70 for WS calves prior to the administration of an extract. 
The average polymorphic neutrophils percentages were 16 and 23 
respectively. One week after the administration of thymosin in 
phosphate buffer the lymphocytes and polymorphic neutrophils average 
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Table 11 Differential WBC average counts for 1-2.month old calves 
Neutrophils 
Group Number Juvenile Segmented Lymphocytes Monocytes 
Normal calves 
Before admin. 5 ^.2 12.2 76.6 7.0 
After thymosin 3 1.0 35.3 77.0 3.6 
After BSA 2 1.5 12.5 84.5 2.0 
VS calves 
Before admin. 7 ^.0 18.8 69.6 3.8 
After thymosin 
in phosphate 
buffer 4 2.3 28.9 61.2 6.3 
After thymosin 
in peanut oil 2 4.5 21.5 ?2.0 6.5 
After BSA 1 1.0 15.0 82.0 1.0 
Normal values (66) 26 
Range 
23.7 
12 - 38 
68 
12 - 80 
3.2 
1 - 5  
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percentages for WS calves were 62 and 31 percent respectively ami 72 
and 26 respectively for calves given thymosin in peanut oil. One 
of the two WS calves given BSA had a differential count of 22 percent 
lymphocytes and 77 percent polymorhpic neutrophils. The high percentage 
of polymorhpic neutrophils indicates an infection, probably of bacterial 
or protozoan etiology. Therefore, the resutls for this calf were not 
included. The other WS calf injected with BSA had 82 percent lympho­
cytes and 16 percent polymorhpic neutrophils. The high percentage 
of lymphocytes is normal for cattle. The values obtained are within 
the range for lymphocytes of 42 and 80 percent with an average of 
68 and for polymorhpic neutrophils the range is 12 to 38 percent 
with an average of 23 percent (66). 
The absolute number of lymphocytes per mm^ of peripheral blood 
(AL/mnP) can be determined by multiplying the WBC count by the percentage 
of lymphocytes. To determine if there is an increase in absolute 
number of lymphocytes with the administration of thymosin, the AL/mm^ 
was determined for the calves of this test group. The AL/mnP for 
each test animal of normal and weak calf groups is tabulated in table 
12. The average AL/mnP for normal calves and WS >calves was 6846 
and 5072 repsectively. There was a significant difference (p=..05) 
between normal calf and WS calf groups prior to any administration 
of test materials. 
The average AL/mm for those normal calves given thymosin increased 
from 7318 to 7448 and for WS calves the average decreased from 4768 
to 4759. The AL/mm^ dropped in two normal calves, W26 and Y89, and 
in one WS calf, Y75. For calves given thymosin in peanut oil, there 
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Table 12 Tabulation of absolute lymphocytes per ram^ (AL/mm3) for 
normal and WS calves 1-2 months old 
Group Calf MBC count % lymphocytes AL/mm--
Normal 
Prior to any administration of thymosin or BSA 
Y84 10,350 78 8073 
W26 8050 85 6243 
Y89 8800 80 7040 
W34 10,930 70 7651 
Y96 6600 70 4620 
After administration of thymosin in phosphate buffer 
Y84 11,300 90 10,170 
W26 7400 84 6216 
Y89 10,450 57 5957 
After administration of BSA 
W34 8600 86 7396 
Y96 5600 83 4648 
Weak syndrome 
Prior to administration of thymosin or BSA 
Y75 11,7**0 61 
W89 4800 77 
Y1 6100 60 
Y66 6800 67 
Y103 8400 64 
W78 3980 90 
W32 8120 92 
After administration of thymosin in phosphate buffer 
Y75 7000 62 
Y89 7050 66 
Y1 9600 47 
Y66 7900 70 
After administration of thymosin in peanut oil 
Y103 9000 60 
Y?8 4600 84 
After administration of BSA 
W32 6900 82 
7161 
3696 
3660 
4556 
5376 
3582 
7470 
4340 
^653 
4512 
5530 
5400 
3864 
5658 
^5 
was an increase in the average AL/mm3 from 4479 to 4632. The calves 
of both groups given BSA showed a decrease in average kh/mrt?. The 
administration of thymosin did not increase the AL/mnP in WS calves 
to a level where this group would not be significantly different 
(p <.05) from the normal calves prior to treatment. 
The blood collected during the initial visit was studied to 
obtain the baseline value of blastogenesis. The results of these studies 
are tabulated in table 13. Because of technical problems the blasto­
genesis culture samples for the two calves, ¥78 and Y103, given thymosin 
in peanut oil were not included. The average S.I. shown in figure 7 
for normal calves was 80.9 ranging from 59.5 to 92.7, whereas, the 
WS calf average S.I. was 47.5 ranging from 23.1 to 57-6. These data 
indicate that there is a significant difference (p < .05) between the 
S.I. of normal calves and WS calves prior to any administration of 
test materials. The S.I. for normal calf group after treatment shown 
in figure 7 rose to 106 but the results from calf W34 and W26 were 
disregarded; the low S.I. of 10 and 8 respectively for these calves 
appeared to result from nonspecific stimulation of the T-cells of control 
samples. The two normal calves, Y84 and Y89, given thymosin in 
phosphate buffer showed an average S.I. of 153. This very high S.I. 
resulted from the very low uptake of tritiated thymidine by the 
lymphocytes of the control cultures. The average S.I. for WS calves 
indicated in figure 7 given thymosin was 55 with a range of 30.3 to 
77.5. The one WS calf given BSA showed a S.I. of 102, but the other 
calf, Y63, was not included because of an apparent infection. After 
the WS calves were treated with tymosin, there was no significant 
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Table 13 Tabulated data for PHA stimulated blastogenesis cultures 
for normal and WS 1-2 month old calves prior to and 
after administration of thymosin or BSA 
No PHA PHA 
culture culture 
Group Calf counts counts S.I,(a) G.G.(b) 
Normal Prior to administration of thymosin or BSA 
Y84 45(c) 4168(c) 92.6 4123 
Y89 61 5811 95.9 5750 
W26 40 2359 59.5 2319 
W34 56 4268 74.2 4212 
Y96 65 5330 82.1 5265 
: administration of thymosin 
Y84 69 5694 82.5 5625 
Y89 37 3030 81.2 2993 
W26 200 1539 7.7 1339 
After administration of BSA 
¥34 181 1827 10.1 1746 
Y96 20 3056 152.8 3036 
Weak syndrome Prior to administration of thymosin or BSA 
Y75 126 7229 57.3 7103 
W89 285 6607 23.1 6322 
Y1 38 2077 55.^ 2039 
Y66 105 4054 38.5 3949 
Y121 18 977 53 959 
W32 81 4660 57.6 4579 
After administration of thymosin 
Y?5 94 2844 30.3 2750 
W89 98 4494 45.8 4396 
Y1 21 1628 77.5 1607 
Y66 38 2586 68.1 2548 
Y121 Calf expired during the study 
After administration of BSA 
W32 57 5798 101.7 5741 
(a) S.I. = stimulated culture counts/control culture counts 
(b) G.G. = stimulated culture counts - control culture counts 
(c) Each value expressed in counts per minute is the average of 
triplicate cultures counted twice. 
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Figure 7 Bar graph representing the 
S.I. from blastogenesis cultures of 
PHA stimulated cultures of 1-2 months 
old normal and WS calves prior to and 
after administration of thymosin. 
Bar lines represent range. 
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difference (p"> .05) between the S.I. of this group and the S.I. of 
normal calves prior to any treatment. There was no significant differ­
ence (p >.05) between the S.I. of normal and VfS calves after adminis­
tration of thymosin. However, the data of calf W32 was not considered 
and the S.I. for the remaining two calves was higher than the S.I. 
of any weak calf. Because of the small sample size for calves 
treated with BSA, statistical analysis could not be computed. 
There was adequate uptake of tritiated thymidine by PHA-P 
stimulated lymphocytes shown by the fact that most cultures had around 
2000 cpm. The average G.G. for normal calves indicated by the bar 
graph in figure 8 was 4334 cpm with a range of 2319 cpm to 5750 cpm. 
The WS calf average G.G. was 4159 with a range of 959 cpm to ?103 
cpm. Using the Mann-Vhitney statistical analysis, there was no 
significant difference between the two groups of test animals. The 
C.G. for the two normal calves, Y84 and Y89, after administration of 
thymosin in phosphate buffer was 4308 cpm. The G.G. of calf Y96 
given BSA measured 3036 cpm. The MS calves given thymosin in phosphate 
buffer exhibited an average G.G. of 2825 cpm with a range of 1607 
cpm to 4396 cpm, and the calf W32 given BSA exhibited a G.C. of 5?4l. 
Studies Involving calves 8-9 months old 
The effect of thymosin on 8-9 month old calves was tested in order 
to establish an understanding of the effect of thymosin in older 
calves. The animals were selected from Mr. Van Meter's herd. Care 
was taken to select calves about the same age and not to include 
calves previously used. Although the date of birth for each calf 
Figure 8 Bar graph representing the 
culture counts from blastogenesis 
cultures of PHA stimulated cultures of 
1-2 month old normal and VS calves 
prior to and after administration of 
thymosin. Bar lines represent range. 
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could not be established, the calves were all born in February and 
March 1975 and were, therefore, 8 to 9 months old when tested. The 
calves were kept separated from the herd and fed daily. The blood 
was drawn by Dr. lifard while the calves were held in a squeeze chute. 
The administration of test materials was done by intramuscular 
injection while the calves were in the chute. The selection of calves 
shown in table 1^ was made by Dr. Ward using the criteria outlined 
previously. A total of six "normal" calves and eight "weak syndrome" 
calves was included in the testing. To show the significant differ­
ence between the size of normal and WS calves, the calves were weighed. 
The weight for normal calves ranged from ^10 pounds to 530 pounds with 
and average weight of 4-50 pounds, whereas, the average weight of WS 
calves was 236 pounds with a range from 185 to 275 pounds. There was 
a significant difference (p <^.05) between the two groups of aminals. 
The schedule and dose of injected materials were changed from 
previous tests. An injection of BSA (20,000^ugm/calf) was administered 
after the initial blood sample was drawn. The second blood sample 
was drawn a week later as well as the administration of thymosin 
(20,000 jugm/calf) in 0.1 M phosphate buffer to each calf. One week 
later the final blood sample was collected. With each blood sample 
collected, WBC count, differential WBG counts and blastogenesis studies 
were completed. 
Table 7 shows the average WBC count obtained for each group of 
calves during the initial visit. The average WBG count and range for 
normal and WS calves was 8767 (7^00 - 11,^0) and 7775 (6700 - 9200) 
respectively. The average WBG count for normal calves increased to 
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Table 14 Pertinent information for calves 8-9 months old 
Identification 
Owner number Weight Comments 
Van Meter R62 430 Normal calf 
Van Meter R43 530 Normal calf 
Van Meter R84 410 Normal calf 
Van Meter W? 455 Normal calf 
Van Meter W127 450 Normal calf 
Van Meter Y106 425 Normal calf 
Van Meter 39401 225 WS calf 
Van Meter W38 205 WS calf 
Van Meter Wl8 2?5 WS calf 
Van Meter W108 265 WS calf 
Van Meter W120 185 WS calf 
Van Meter Will 260 WS calf 
Van Meter Y119 250 WS calf 
Van Meter Y46 220 WS calf 
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9232 (7300 - 11,200) after the administration of BSA and to 896? 
(?200 - 12,600) after the administration of thymosin. For WS calves 
the average WBC count after the injection of BSA decreased to 7538 
(6300 - 8900) and after thymosin increased to 8571 (5700 - 9800). 
The differential showed that the distribution of polymorphic neutro­
phils and lymphocytes was similar in both test groups. There was no 
significant increase in the percentage of lymphocytes after administra­
tion of BSA or thymosin. The data is summarzied in table 15. 
The absolute lymphocyte number per mm^ of peripheral blood (AL/mirP) 
was determined as previously stated. The data for each animal is 
tabulated in table 16. The average and range for normal calves was 
6898 (5328 - 8778) AL/mrP prior to any injection of test materials. 
The average increased, for normal calves after BSA administration 
7570 (5986 - 10,192) AL/nuP } after thymosin administration the 
average AL/mnP was 7071 (6192 - 8820). There was in increase in AL/nmP 
in WS calf average to 6181 (4810 - 8064). Prior to the administration 
of BSA, there was a significant difference (p <.05) between AL/mm^ for 
normal and WS calves. However, after BSA administration there was 
no significant difference (p<.10) as was also seen after administra­
tion of thymosin (p> .10), and the probability factor (p factor) was 
larger after administration of thymosin than after administration 
of BSA. 
Technical problems with the incubation system for blastogenesis 
caused the data obtained to be disregarded. Although blastogenesis 
cultures were established, there was too much variability in the 
results obtained for the results to be useful. 
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Table 15 Differential HBC average counts for 8-9 month old calves 
Neutrophils 
Group Nuaber Juvenile Segmented. Lymphocytes Monocytes 
Normal calves 
Before admin. 6 2.8 10.7 78.7 *K3 
After BSA 6 1.2 10.5 81.8 2.5 
After thymosin 6 1.3 11.5 80.0 3.6 
YS calves 
Before admin. 8 3.6 15.3 72.5 5.9 
After BSA 8 2.5 11.0 81.5 2.3 
After thymosin 7 3.0 1^.1 7^.0 5.0 
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Table 16 Tabulation of absolute lymphocytes per mm3 (AL/mm3) for 
normal and WS calves 8-9 months old 
Group Calf WBC count % lymphocytes AL/mm3 
Normal Prior to administration of BSA 
R62 11,400 7? 8778 
H43 9800 80 7840 
R84 8000 77 6l60 
¥7 8000 82 6560 
W12? 7400 72 5328 
Y106 8000 84 6720 
After BSA administration 
R62 11,100 79 8769 
R43 11,200 91 10,192 
R84 9500 81 7695 
*7 7700 85 6545 
¥127 8600 73 6278 
Y106 7300 82 5986 
After thymosin administration 
R62 12,600 70 8820 
R43 9000 74 6600 
R84 8600 83 7138 
¥7 7300 88 6424 
¥127 7200 86 6192 
Y106 9100 79 7189 
Weak syndrome Prior to administration of BSA 
S9401 9200 
W38 6700 
¥18 7100 
¥108 8100 
¥120 6700 
¥111 8300 
Y119 8800 
Y46 7300 
After BSA administration 
S9401 8600 
¥38 6300 
¥18 6500 
¥108 8400 
¥120 7300 
¥111 8900 
¥119 7700 
Y46 6600 
After thymosin administration 
S9401 8200 82 6724 
¥18 6500 59 3835 
¥108 9200 77 7084 
¥120 7600 62 4712 
¥111 9200 72 6624 
¥119 9500 78 7410 
Y46 9800 88 8624 
¥38 5700 Not available 
67 6l64 
81 5427 
71 5041 
81 6561 
66 4422 
69 572? 
64 5632 
81 5913 
80 6880 
80 5040 
74 4810 
96 8064 
75 5475 
73 6497 
86 6622 
88 5808 
Chapter 4 
DISCUSSION 
Selection of calves 
Since the University of Montana does not have a bovine test herd 
or facilities for housing large animals, this study had to be done 
with calves on the owner's ranches within the Bltterroot Valley. Dr. 
Ward made the initial arrangements with the ranchers to allow their 
calves to be used in these experiments. Although inherent problems were 
encountered, these arrangements were necessary to obtain any data. 
By using a group of animals fifty miles from the laboratory, 
however, transportation of samples created a major problem. The blood 
samples requently arrived at the laboratory six hours after collection. 
On several occasions the samples were received on the following day 
after being drawn. To add to the complication, these samples were left 
either in a cooler in the truck used by Dr. Ward or in the clinic at 
unknown temperatures until transported to the laboratory. The vari­
ability of some of the data could have been due to these conditions. 
The most ideal situation was to be present when the blood samples 
were drawn as was done during the bleeding of one-month and older 
calves. However, samples from newborn weak syndrome(WS) calves were 
another matter since the birth of such calves could not be predicted. 
Dr. Ward drew blood from these diseased animals only when the oppor­
tunity arose. 
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Calves are obviously of economic value to the rancher, but the 
depressed cattle market decreased the attempts of many ranchers to 
save animals with severe afflictions. In the case of the WS calves, 
the problem was magnified since previous therapy with whole immune 
serum that had "saved" numerous calves did not alleviate the runting 
condition associated with the syndrome. Therefore, weight gain of 
normal calves was approximately 100# greater after one year that in 
VS calves. Since the runted animals consumed almost as much feed as 
the normal ones, the financial return was considerably less. In view 
of the above conditions, the rancher was reluctant to incur the addi­
tional expense of procuring the services of a veterinarian. Since 
Dr. Ward was depended upon to collect the materials from the diseased 
animals, samples became increasingly difficult to obtain. 
The pool of available calves that could be used was further 
reduced since calves from previous herds given thymosin or passive 
immune therapy were not suitable for the study of chronic calves. 
Thymosin had been administered to a number of animals during the 
spring of 197^. Thymosin and passive immune therapy was given to 
a large population of calves belonging to several ranchers who had 
been particularly cooperative during the studies of the WS calf by 
this laboratory. Therefore, herd animals without previous exposure 
to thymosin or immune serum was desired, but locating these types of 
herds was difficult. 
Just prior to the spring of 197^» Mr. Van Meter moved into the 
valley from eastern Montana. He brought several head of cattle from 
elsewhere and purchased cattle from other ranchers in the Bitterroot 
57 
area to establish his herd. Not aware of the disease problem 
prevalent in the area, he was perplexed during the first year when 
his pregnant heifers began to abort or give birth to calves unable to 
stand and nurse. After losing a large number of his calf crop the 
first year, Mr. Van Meter contacted Dr. Ward who diagnosed the 
problem as the weak calf syndrome. The next spring, 1975• Mr. Van 
Meter lost 23% of his calf crop. When he learned of our interest 
in conducting studies with thymosin using a herd not previously 
exposed to any test materials, he expressed his desire to provide the 
necessary animals from his herd for our limited studies. 
During the testing of thymosin on calves under one month of age, 
there was a tendency to treat all WS calves with thymosin and not to 
include control animals injected with a placebo. Since the adminis­
tration of thymosin to some calves during the spring of 197^ resulted 
in dramatic improvements, the ranchers understandably desired to 
treat all, including normal, calves with thymosin. The desired 
procedure was to use one herd to test all materials, a situation 
provided by Mr. Van Meter. Since neither the rancher nor Dr. Ward 
was aware of which injections each calf received, proper control 
measures were maintained. 
Scheduling of the bleeding and administration of test materials 
were made by Dr. Ward, Since young calves were still nursing, all 
animals were retained with the herd during the study. The arrangement 
had its difficulties in that the calves desired for bleeding or injec­
tion were intermingled with the other non-testing cattle. Therefore, 
in addition to sorting the test animals, reliance had to be upon 
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Mr. Van Meter to rope the calves. 
Older calves did not create as much difficulty in that they were 
corralled and kept separate from the herd. This arrangement was more 
suitable since less help was needed and the collection time was 
reduced, but Mr. Van Meter also absorbed the additional expense of 
feeding these animals for the three-week period. 
On occasion the scheduling of all the persons necessary for the 
bleeding and injections was difficult to coordinate. For example, 
the time intervals required for bleeding and injection of animals 
could not always be coordinated, and delays were the frequent conse­
quences. The blastogenesis assays for newborn WS calves given thymosin 
should have been performed within two weeks after the injection instead 
of two months later. 
Visual observation of thymosin therapy 
Although the serum therapy used previously was undoubtedly 
responsible for the survival of numerous diseased calves, their general 
health did not necessarily improve. The calves were susceptible to 
secondary infections especially those leading to scours. Although the 
treated calves were frequently able to stand and to nurse, several of 
these animals had to be bottle fed or had to have their heads held 
while nursing, Even six months later when lymph node excision was done 
on two of these animals, the lesions required over a month to heal 
whereas, the lesions due to lymph node excision in normal calves 
healed within b8 hours. 
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Since immune serum was tedious to prepare and, as stated earlier, 
the WS calves showed thymic atrophy and involution, the administration 
of thymosin was attempted. With three injections of thymosin (1000 pgm 
each) on alternate days dramatic improvements were observed. An example 
of the observations made by Dr, Ward following this schedule of 
injections during preliminary studies during the spring 197^ is 
as follows: 
day of 1st injections calf docile, unable to nurse or stand, 
typical WS calf 
day of 2nd injections calf able to stand, began to nurse, 
increased mobility since able to walk 
day of 3rd injections calf nursed vigorously, can not be 
approached, had to be roped to administer 
the injection, running with increased 
agility 
After thymosin administration, calf scours were either reduced or 
controlled, particularly upon continued therapy. 
As stated above the general health of most WS calves improved 
within a couple days after the first injection. The rapid improvement 
seen when the WS calves were given thymosin suggested that the agent 
does more than reconstitute the T-cell mediated immune functions. 
Although the immunocompete peripheral T-cells increased with thymosin, 
an effect upon the horraaaal balance of WS calves is suggested in view 
of the dramatic and rapid improvement observed. The thymus had been 
implicated as affecting the production of growth hormone and thyroxine 
(.57)* With injection of thymosin the production and utilization of 
these and other hormones could have been stimulated in the WS calves. 
If the thymus is involved in regulation of growth hormone and thyroxine 
in calves, then the administration of thymosin could reverse the runting 
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syndrome of WS calves and result In more rapid weight gain. Beneficial 
effects in normal calves such as increased weight gain per pound of 
feed may also occur. Further investigation over several years would 
be required to establish the validity of this hypothesis. However, 
the improvement of WS calves had regressed in some animals after one 
week if only one injection of thymosin was administered. The regres­
sion of improved health observed when thymosin injections were not 
continued gives further support to the hypothesis that the thymus 
has a hormonal function, at least in calves. 
Several calves severely afflicted still died even after thymosin 
was administered. The condition of these animals had deteriorated 
beyond the point that therapy was unavailable. On the other hand, 
whether more concentrated and frequent injections of thymosin could 
have improved the prognosis of these types of calves is speculative. 
Blastogenesis study 
The mitogen, phytohemagglutinin (PHA), induces T-cells to undergo 
blast-like transformation. The stimulation can be measured by the 
uptake of tritiated thymidine during mitosis and can be used as a 
basis for evaluating the population of immunocompetent T-cells in the 
peripheral blood. Since the thymus of WS calves has been shown to be 
involuted (53)» the response of the peripheral T-cells to PHA stimulation 
was used as an index of the status of the cellular immune system. 
A summary of the blastogenesis data is given in table 1?. Newborn 
normal calves have a lower or depressed response as compaxed to calves 
1-2 months old. A statistically significant difference (p<.05) was 
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Table 1? Summary of S.I. and. G.C. data for normal and WS newborn 
and 1-2 month old calves 
Calf group 
Normal, newborn 
Normal, 1-2 months old 
After thymosin (c) 
After BSA 
Weak syndrome, newborn 
Weak syndrome, 1-2 months old 
After thymosin (c) 
After BSA 
Thymosin at birth (d) 
Number Average Average 
calves S.I, (a) C.C. (b) 
8 12.9 bob 
5 80.9 4334 
2 81.9 4309 
1 152.8 3036 
8 1.5 101 
6 ^7.5 *H58 
k 55A 2852 
1 101.7 2118 
6 60.9 1319 
(a) S.I. = stimulated culture counts/control culture counts 
b) G.C. «= stimulated culture counts - control culture counts 
c) Thymosin and BSA (1000 jxgm/injection) were given one week prior 
to the blood samples being taken. 
(d) Calves of this test group were given thymosin (1000 }igm) at 
birth. Blood samples were taken when the calves were 2 months old. 
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measured when the data was analyzed by the Mann-Whitney U test. The 
depression was also noted when the mitogenic response of newborn WS 
calves was compared to 1-2 month old WS calves. The generalized 
depression observed in newborn animals could be a result of the high 
concentration of corticosteriods reported to be present in the 
circulatory system of fetuses prior to parturition (51). 
The S.I. and G.G. calculated from the mitogenic response data 
of newborn normal calves were significantly different from that of 
newborn WS calves. Although no significant difference was measured in 
the C.G. between the two groups of 1-2 month old calves, a difference 
was noted in calculating the S.I. data. The results show that suppres­
sed peripheral T-cell population is an indication of involuted thymuses 
in WS calves. The involution could be the result of a direct invasion 
of the organ by an infectious agent or a stress response induced by 
the infectious process. In any case, susceptibility of these animals 
to secondary infections was no doubt increased by the involution and 
depressed peripheral T-cell population. 
The competence of the cell-mediated immune system is routinely 
determined by the ability of sensitized animals to elicit a delayed 
hypersensitivity (DH) reaction to skin test antigens. In cattle a 
DH reaction to protein derivative of tuberculin in animals naturally 
infected with Mycobacterium bovis or given the BGG strain of M. bovis 
requires a dose of 400 tuberculin units. In contrast, the maximum 
of 5 tuberculin units is used in man. A DH reaction could not be 
elicited in WS calves even though several injections of BGG had been 
administered previously. With failure to elicit a DH reaction, the WS 
63 
calves were thought to be depleted of Immunocompetent T-cells, However, 
the results from calves tested at the Van Meter ranch indicated the 
presence of T-cells responding to PHA stimulation in chronic WS calves. 
Therefore, the chronic WS calves do have immunocompetent T-cells 
although this population is depressed. 
After the administration of thymosin the average S.I. of 1-2 
month old WS calves, as shown in table 17, increased. When compared 
to the S.I. of normal calves prior to treatment, the increased S.I. 
for WS calves was not significantly different (p>.05). There was also 
no significant difference between the S.I. of normal and WS calves after 
the administration of thymosin. It should be kept in mind that the 
normal group consisted of only two calves, which obviously make the 
comparison of the data questionable. Since no significant difference 
was noted between the WS group after treatment and the normal group 
prior to treatment with thymosin, the results indicate that thymosin 
induced mature immunocompetent T-cells to appear in the peripheral 
blood circulation of WS calves. Two mechanisms could be responsible 
for this increase in immunocompetent T-cells. However, it is not 
possible to distinguish if the increase was caused by a release of 
mature T-cells from the thymus or if thymosin actually induced the 
maturation of T-cells in the circulating blood. The fact that thymosin 
has been shown to restore cell-mediated immunity to neonatal thymecto-
mized mice (42) would seem to indicate that the latter hypothesis is 
appropiate. 
As newborn WS calves given thymosin were approximately two months 
old before the second blastogenesis study was completed, this group 
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can be compared to calves tested at the Van Meter ranch. The Mann-
Vfhitney U test showed no significant difference between the S.I. of 
newborn WS calves given thymosin immediately after birth and normal 
or WS calves 1-2 months old prior to treatment. The observation 
indicated that thymosin administration did induce a mature T-cell 
population in these newborn calves, but one injection of 1000 ̂ igm 
was inadequate to increase the level of response to that seen in 
normal calves. Based on these results, the therapy should include 
more concentration of the preparation and increased frequency of 
treatment. 
Some of the technical problems encountered during the blasto-
genesis study included the incubation temperature and variability of 
the amount of radioactive thymidine uptake. When the incubation 
temperature of the lymphocyte cultures was increased to 39° C, blast­
like transformation of the cells in the presence of PHA could not be 
measured. During the blastogenesis studies of 8-9 month old calves, 
the incubator failed to operate properly. The temperature of over 
39° C was noted in the incubator. Variability of thymidine uptake by 
"stimulated" lymphocytes was observed. At times a ten-fold difference 
was recorded between triplicate cultures of the same test sample, and 
these counts were not used in the calculations. Since the concentration 
of PHA used was in the high range, some of the variability could be 
attributed to the high concentration of PHA (23). 
Effects of thymosin on lymphocyte numbers 
To determine the effects of thymosin administration on the number 
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of lymphocytes per volume of blood, an absolute lymphocyte number 
analysis was performed using two groups of chronic calves at the 
Van Meter ranch. The first group consisted of 1-2 month old calves 
and were also used in the blastogenesis study. The second group of 
calves 8-9 months old was selected from Van Meter's spring 1975 calf 
crop seven months later. 
The absolute lymphocytes number per mm^ of peripheral blood (AL/miiP) 
for both age groups showed a significant difference between normal and 
WS calves prior to any injection of thymosin. After thymosin was 
administered to 1-2 month old calves an increase in the AL/mm3 was 
observed. This increase in AL/mm^ was also noted in most normal 8-9 
month old calves given BSA, but a decrease in AL/ranP was observed for 
8-9 month old WS calves when administered BSA. With the administration 
of thymosin the AL/mm^ increased in most calves, but some showed a 
decrease in AL/mm3, 
The increase of AL/mm3 was only about 100 lymphocytes in most 
cases after injection of either BSA or thymosin. The small increase 
could possibly be attributed to differences in the differential. The 
difference would be magnified since the lymphocyte count was multiplied 
by the total WBC count. Brown (ll) stated that there could be a 10-15% 
difference in the cell counts when performing the differential WBC 
count. Therefore, the small increase of 100 lymphocytes does not 
seem sufficiently large to account for the increase in S.I, noted after 
injection of thymosin in the 1-2 month old WS calves. This would 
tend to support the hypothesis that thymosin causes the maturation 
of T-cells in peripheral blood rather than the release of mature 
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T-cells from the thymus. At the present time sufficient data is 
not available to support either mechanism. 
The rosette formation by peripheral lymphocytes has been used 
to assay the T-cell population of peripheral blood (78). In a 
human patient there had been reported an increase in the number of 
lymphocytes as well as an increase in the percentage of T-cell rosettes 
with thymosin injections (77). This assay system could not be 
performed during the course of the study on WS calves because of the 
problems encountered when lymphocytes were separated from erythrocytes. 
When the separation and purification of bovine calf peripheral 
lymphocytes can be perfected, the rosette formation would probably 
be a more effective means of ascertaining whether the administration 
of thymosin increased the circulating peripheral T-cells. 
Chapter 5 
SUMMARY 
Upon study of the calf afflicted with the weak calf syndrome, the 
absence of a normal thymus development was observed. It was also 
observed that weak syndrome calves could not elicit a delayed 
hypersensitivity skin reaction to purified protein derivative of 
tuberculin even after repeated injection of Mycobacterium bovis 
strain BCG. The absence of delayed hypersensitivity was hypothesised 
to be a result of a depressed or absent thymic lymphocyte (T-cell) 
population. Since neonatal thymectomized mice given thymosin were 
able to reconstitute a functional T-cell population, thymosin was 
believed to have a similar effect on weak syndrome calves. More 
specifically, the immunocompetence of the peripheral T-cell 
population in weak syndrome calves was monitored to determine if 
administration of thymosin reconstituted the T-cell population. The 
immunocompetence of the peripheral T-cell population in weak syndrome 
and normal calves was determined before administration of thymosin. 
Uptake of tritiated thymidine by phytohemagglutinin(PHA) was used to 
monitor the immunocompetence of the peripheral T-cell population. This 
type of assay measures the stimulatory effect of the non-specific 
mitogen PHA on the T-cell population which can be used to determine the 
immunocompetence of this lymphocyte population. Whole blood was used 
for the blastogenesis cultures since the physical separation of 
peripheral lymphocytes could not be attained in calf peripheral 
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"blood samples. The immunocompetence of the T-cell population was 
determined prior to and after one injection of thymosin (lOOO^igm). 
Both weak syndrome and normal calves of varying ages were used. To 
determine if thymosin would Increase the number of lymphocytes in the 
peripheral blood total and differential WBC counts were performed 
at the time blastogenesis cultures were done. 
It was determined that the T-cells from weak syndrome calves would 
take up a significantly lower amount of radioactive thymidine than the 
T-cells from normal calves. After administration of thymosin there 
was no significant difference in the amount of tritiated thymidine 
uptake between the T-cells from both calf groups. Any increase in the 
total lymphocytes after thymosin was not large enough to account for 
the increased stimulatory effect seen in T-cells from weak syndrome 
calves. Therefore, it was hypothesised that thymosin induced the matura­
tion of peripheral T-cells in weak syndrome calves. An added effect 
of administration of thymosin which was not fully understood was the 
very rapid improvement in the general health of weak syndrome calves 
after one injection of thymosin. 
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